Adaptive evaluation of Boron Neutron Capture Therapy (BNCT) using F-18 FBPA PET

Adaptive evaluation of Boron Neutron Capture Therapy (BNCT) using F-18 FBPA PET - Adaptive evaluation of BNCT using FBPA PET

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031323

Enrollment

Registered

2018-03-01

Start date

2018-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain tumor Head and neck tumor Other tumors(digestive organs, lung, skin, blood tumor etc.)

Interventions

FBPA is administered intravenously to the tumor patients. Tumor patients are imaged using PET-CT.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. 50 tumor patients who can not expect the effect of other treatments (surgery, radiotherapy, and chemotherapy) 2. Age; 20-70 years-old 3. Written informed consent is obtained. 4. Tumor patients not applicable to exclusion items

Exclusion criteria

Exclusion criteria: 1. A pregnant woman, a lactating subject, or a person who wishes to become pregnant 2. Child 3. A patient who should not be recruited to the clinical trial as determined by the investigators

Design outcomes

Primary

Measure	Time frame
Estimation of boron (10 B) concentration in tumor Adaptive evaluation of BNCT	—

Secondary

Measure	Time frame
Prediction of side effects of BNCT in normal tissues	—

Countries

Japan

Contacts

Public ContactJun Hatazawa

Osaka University Graduate School of Medicine Department of Nuclear Medicine and Tracer Kinetics

hatazawa@tracer.med.osaka-u.ac.jp06-6879-3461

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026